Meet with us at CNS Summit!
CNS Summit convenes life sciences leaders to explore the future of drug development, from artificial intelligence and digital biomarkers to novel endpoints, site engagement, and clinical trial innovation. Turning these advances into meaningful progress requires scientific strategy and operational execution to move together.
Premier Research Chief Executive Officer John Ratliff and Chief Operating Officer Siân Ratcliffe Smethurst will join our neuroscience leaders at CNS Summit 2026 to connect with organizations advancing CNS therapies. With experience across more than 210 CNS projects in the past five years, our integrated full-service teams combine therapeutic expertise with study design, start-up, clinical operations, data, safety, and regulatory support across the development lifecycle.
Connect with our team to discuss:
- Fit-for-purpose study design and execution strategies for complex CNS programs
- Patient and site identification, recruitment, retention, and engagement
- Biomarker integration, endpoint quality, and data-driven trial oversight
- Cross-functional delivery, risk management, and technology-enabled execution
On-Site
- John Ratliff, Chief Executive Officer
- Siân Ratcliffe Smethurst, Chief Operating Officer
- Andreas Schreiner, Senior Vice President, Medical Affairs
- Krista Armstrong, Senior Vice President, Neuroscience
- Melissa Snyder, Executive Director, Program Strategy
- Laurie Willis, Executive Director, Program Delivery
- Sofie Reynders, Project Director
- Cameron Griffin, Senior Project Manager
- Vanessa Martucci, Senior Project Director, CNS
Fill out the form above to schedule a meeting with our on-site team.
Schedule time with our executive and neuroscience leadership to discuss your development priorities and upcoming clinical programs.
